<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss1full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.nature.com/~d/styles/itemcontent.css"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0">
<channel rdf:about="http://www.nature.com/nm/current_issue/rss">
<title>Nature Medicine - Issue - nature.com science feeds</title>
<description>Nature Medicine is the premier journal for biomedical research. Respected internationally for the quality of its papers on areas ranging from infectious disease to cancer and neurodegeneration, Nature Medicine aims to bridge the gap between basic research and medical advances and is consistently ranked the number one journal by the Institute of Scientific Investigation in the Medicine, Research and Experimental category.</description>
<link>http://www.nature.com/nm/current_issue/</link>
<admin:generatorAgent rdf:resource="http://www.nature.com/" />
<admin:errorReportsTo rdf:resource="mailto:feedback@nature.com" />
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights>© 2012 Nature Publishing Group</dc:rights>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:issn>1078-8956</prism:issn>
<prism:eIssn>1546-170X</prism:eIssn>
<prism:copyright>© 2012 Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/includes/rj_globnavimages/nm_logo.gif" />
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2777" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm0512-633" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm0512-634" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm0512-636a" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm0512-636b" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm0512-637" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm0512-638" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm0512-639" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm0512-640" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm0512-642" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm0512-644" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm0512-646" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2751" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2733" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2734" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2769" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2767" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2773" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2761" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2762" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2765" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2770" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2747" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2748" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2781" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2783" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2785" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2779" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2787" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2789" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2731" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2737" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2755" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2760" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2678" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2768" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2754" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2735" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2736" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2693" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2728" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2709" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2717" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2729" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2700" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2692" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2724" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2720" />
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nm.2721" />
</rdf:Seq>
</items>
<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rdf+xml" href="http://feeds.nature.com/nm/rss/current" /><feedburner:info uri="nm/rss/current" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /></channel>
<image rdf:about="http://www.nature.com/includes/rj_globnavimages/nm_logo.gif">
<title>Nature Medicine</title>
<url>http://www.nature.com/includes/rj_globnavimages/nm_logo.gif</url>
<link>http://www.nature.com/nm/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/nm.2777">
                     <title>A fresh perspective on asthma</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/GLvBBzfBv6Q/nm.2777</link>
<description />
<content:encoded><![CDATA[
<div style="white-space: nowrap;"><img src="http://www.nature.com/common/includes/header/images/backgrounds/01/leaderboard_side.gif" alt="" style="width: 14px; border: 0; margin: 0; padding: 0; display: inline;" /><a href="http://ad.doubleclick.net/jump/medicine.nature.com/rss;abr=!NN2;pos=top;sz=728x90;tile=1;ptile=1;ord=123456789?"><img src="http://ad.doubleclick.net/ad/medicine.nature.com/rss;abr=!NN2;pos=top;sz=728x90;tile=1;ptile=1;ord=123456789?" alt="Advertisment" style="border: 0; margin: 0; padding: 0; display: inline;" /></a><img src="http://www.nature.com/common/includes/header/images/backgrounds/01/leaderboard_side.gif" alt="" style="width: 14px; border: 0; margin: 0; padding: 0; display: inline;" /></div><p>
<b>A fresh perspective on asthma</b>
</p>
<p>Nature Medicine 18, 631 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2777">doi:10.1038/nm.2777</a>
</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/GLvBBzfBv6Q" height="1" width="1"/>]]></content:encoded>
<dc:title>A fresh perspective on asthma</dc:title>
<dc:identifier>doi:10.1038/nm.2777</dc:identifier>
<dc:source>Nature Medicine 18, 631 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2777</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2777</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Editorial</prism:section>
<prism:startingPage>631</prism:startingPage>
<prism:endingPage>631</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2777</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm0512-633">
                     <title>Hopes soar as cholesterol plummets with new drug class</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/aymHTC1jUHs/nm0512-633</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Hopes soar as cholesterol plummets with new drug class</b>
</p>
<p>Nature Medicine 18, 633 (2012).  
            <a href="http://dx.doi.org/10.1038/nm0512-633">doi:10.1038/nm0512-633</a>
</p>
<p>Author: David Holmes</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/aymHTC1jUHs" height="1" width="1"/>]]></content:encoded>
<dc:title>Hopes soar as cholesterol plummets with new drug class</dc:title>
<dc:creator>David Holmes</dc:creator>
<dc:identifier>doi:10.1038/nm0512-633</dc:identifier>
<dc:source>Nature Medicine 18, 633 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm0512-633</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm0512-633</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News</prism:section>
<prism:startingPage>633</prism:startingPage>
<prism:endingPage>633</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm0512-633</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm0512-634">
                     <title>Malaria subsidy pilot soars, but some see turbulence ahead</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/eI0B0uiB3SY/nm0512-634</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Malaria subsidy pilot soars, but some see turbulence ahead</b>
</p>
<p>Nature Medicine 18, 634 (2012).  
            <a href="http://dx.doi.org/10.1038/nm0512-634">doi:10.1038/nm0512-634</a>
</p>
<p>Author: Amy Maxmen</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/eI0B0uiB3SY" height="1" width="1"/>]]></content:encoded>
<dc:title>Malaria subsidy pilot soars, but some see turbulence ahead</dc:title>
<dc:creator>Amy Maxmen</dc:creator>
<dc:identifier>doi:10.1038/nm0512-634</dc:identifier>
<dc:source>Nature Medicine 18, 634 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm0512-634</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm0512-634</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News</prism:section>
<prism:startingPage>634</prism:startingPage>
<prism:endingPage>635</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm0512-634</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm0512-636a">
                     <title>Biologic drugs set to top 2012 sales</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/9X5BvhRcx5A/nm0512-636a</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Biologic drugs set to top 2012 sales</b>
</p>
<p>Nature Medicine 18, 636 (2012).  
            <a href="http://dx.doi.org/10.1038/nm0512-636a">doi:10.1038/nm0512-636a</a>
</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/9X5BvhRcx5A" height="1" width="1"/>]]></content:encoded>
<dc:title>Biologic drugs set to top 2012 sales</dc:title>
<dc:identifier>doi:10.1038/nm0512-636a</dc:identifier>
<dc:source>Nature Medicine 18, 636 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm0512-636a</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm0512-636a</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News</prism:section>
<prism:startingPage>636</prism:startingPage>
<prism:endingPage>636</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm0512-636a</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm0512-636b">
                     <title>Targeting hypoxia brings breath of fresh air to cancer therapy</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/KuHIfJ8Xhh4/nm0512-636b</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Targeting hypoxia brings breath of fresh air to cancer therapy</b>
</p>
<p>Nature Medicine 18, 636 (2012).  
            <a href="http://dx.doi.org/10.1038/nm0512-636b">doi:10.1038/nm0512-636b</a>
</p>
<p>Author: Melinda Wenner Moyer</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/KuHIfJ8Xhh4" height="1" width="1"/>]]></content:encoded>
<dc:title>Targeting hypoxia brings breath of fresh air to cancer therapy</dc:title>
<dc:creator>Melinda Wenner Moyer</dc:creator>
<dc:identifier>doi:10.1038/nm0512-636b</dc:identifier>
<dc:source>Nature Medicine 18, 636 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm0512-636b</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm0512-636b</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News</prism:section>
<prism:startingPage>636</prism:startingPage>
<prism:endingPage>637</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm0512-636b</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm0512-637">
                     <title>Billions of dollars for research at stake in health-reform case</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/pHyc0TszbnE/nm0512-637</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Billions of dollars for research at stake in health-reform case</b>
</p>
<p>Nature Medicine 18, 637 (2012).  
            <a href="http://dx.doi.org/10.1038/nm0512-637">doi:10.1038/nm0512-637</a>
</p>
<p>Author: John Otrompke</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/pHyc0TszbnE" height="1" width="1"/>]]></content:encoded>
<dc:title>Billions of dollars for research at stake in health-reform case</dc:title>
<dc:creator>John Otrompke</dc:creator>
<dc:identifier>doi:10.1038/nm0512-637</dc:identifier>
<dc:source>Nature Medicine 18, 637 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm0512-637</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm0512-637</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News</prism:section>
<prism:startingPage>637</prism:startingPage>
<prism:endingPage>637</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm0512-637</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm0512-638">
                     <title>New biologic drugs get under the skin of psoriasis</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/SkWEv5f4QVQ/nm0512-638</link>
<description />
<content:encoded><![CDATA[

<p>
<b>New biologic drugs get under the skin of psoriasis</b>
</p>
<p>Nature Medicine 18, 638 (2012).  
            <a href="http://dx.doi.org/10.1038/nm0512-638">doi:10.1038/nm0512-638</a>
</p>
<p>Author: Sarah C P Williams</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/SkWEv5f4QVQ" height="1" width="1"/>]]></content:encoded>
<dc:title>New biologic drugs get under the skin of psoriasis</dc:title>
<dc:creator>Sarah C P Williams</dc:creator>
<dc:identifier>doi:10.1038/nm0512-638</dc:identifier>
<dc:source>Nature Medicine 18, 638 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm0512-638</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm0512-638</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News</prism:section>
<prism:startingPage>638</prism:startingPage>
<prism:endingPage>638</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm0512-638</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm0512-639">
                     <title>Straight talk with...Chen Zhu</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/i9EWWL4uZrE/nm0512-639</link>
<description>In April, China's Minister of Health Chen Zhu and his mentor, Wang Zhen-yi of the Shanghai Jiao Tong University School of Medicine, received the Albert Szent-Györgi Prize from the Washington, DC–based National Foundation for Cancer Research, in recognition for their work on acute promyelocytic leukemia. On that occasion, Victoria Aranda and Roxanne Khamsi asked Chen about his plans for cancer research and for improving stem cell regulation in China.</description>
<content:encoded><![CDATA[

<p>
<b>Straight talk with...Chen Zhu</b>
</p>
<p>Nature Medicine 18, 639 (2012).  
            <a href="http://dx.doi.org/10.1038/nm0512-639">doi:10.1038/nm0512-639</a>
</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/i9EWWL4uZrE" height="1" width="1"/>]]></content:encoded>
<dc:title>Straight talk with...Chen Zhu</dc:title>
<dc:identifier>doi:10.1038/nm0512-639</dc:identifier>
<dc:source>Nature Medicine 18, 639 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm0512-639</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm0512-639</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News</prism:section>
<prism:startingPage>639</prism:startingPage>
<prism:endingPage>639</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm0512-639</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm0512-640">
                     <title>Biomedical briefing</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/DNZPxEXZijw/nm0512-640</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Biomedical briefing</b>
</p>
<p>Nature Medicine 18, 640 (2012).  
            <a href="http://dx.doi.org/10.1038/nm0512-640">doi:10.1038/nm0512-640</a>
</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/DNZPxEXZijw" height="1" width="1"/>]]></content:encoded>
<dc:title>Biomedical briefing</dc:title>
<dc:identifier>doi:10.1038/nm0512-640</dc:identifier>
<dc:source>Nature Medicine 18, 640 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm0512-640</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm0512-640</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News</prism:section>
<prism:startingPage>640</prism:startingPage>
<prism:endingPage>641</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm0512-640</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm0512-642">
                     <title>Sound medicine</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/dRBve7IWefk/nm0512-642</link>
<description>Everyone from rock stars to nonagenarians experiences hearing loss, but no drugs have ever been approved specifically to prevent or treat this problem. Recently, a handful of drug companies have started to make some noise, with a number of experimental compounds now in human trials. Elie Dolgin sounds off on what could be a multibillion dollar market.</description>
<content:encoded><![CDATA[

<p>
<b>Sound medicine</b>
</p>
<p>Nature Medicine 18, 642 (2012).  
            <a href="http://dx.doi.org/10.1038/nm0512-642">doi:10.1038/nm0512-642</a>
</p>
<p>Author: Elie Dolgin</p>
<p>Everyone from rock stars to nonagenarians experiences hearing loss, but no drugs have ever been approved specifically to prevent or treat this problem. Recently, a handful of drug companies have started to make some noise, with a number of experimental compounds now in human trials. Elie Dolgin sounds off on what could be a multibillion dollar market.</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/dRBve7IWefk" height="1" width="1"/>]]></content:encoded>
<dc:title>Sound medicine</dc:title>
<dc:creator>Elie Dolgin</dc:creator>
<dc:identifier>doi:10.1038/nm0512-642</dc:identifier>
<dc:source>Nature Medicine 18, 642 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm0512-642</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm0512-642</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News</prism:section>
<prism:startingPage>642</prism:startingPage>
<prism:endingPage>645</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm0512-642</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm0512-644">
                     <title>Innermost desires</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/Czmj9EV2kHg/nm0512-644</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Innermost desires</b>
</p>
<p>Nature Medicine 18, 644 (2012).  
            <a href="http://dx.doi.org/10.1038/nm0512-644">doi:10.1038/nm0512-644</a>
</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/Czmj9EV2kHg" height="1" width="1"/>]]></content:encoded>
<dc:title>Innermost desires</dc:title>
<dc:identifier>doi:10.1038/nm0512-644</dc:identifier>
<dc:source>Nature Medicine 18, 644 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm0512-644</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm0512-644</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News</prism:section>
<prism:startingPage>644</prism:startingPage>
<prism:endingPage>644</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm0512-644</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm0512-646">
                     <title>The WHO must reform for its own health</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/rt08WP15xyM/nm0512-646</link>
<description>The World Health Organization (WHO) is facing an unprecedented crisis that threatens its position as the premier international health agency. To ensure its leading role, it must rethink its internal governance and revamp its financing mechanisms.</description>
<content:encoded><![CDATA[

<p>
<b>The WHO must reform for its own health</b>
</p>
<p>Nature Medicine 18, 646 (2012).  
            <a href="http://dx.doi.org/10.1038/nm0512-646">doi:10.1038/nm0512-646</a>
</p>
<p>Authors: Tikki Pang &amp; Laurie Garrett</p>
<p>The World Health Organization (WHO) is facing an unprecedented crisis that threatens its position as the premier international health agency. To ensure its leading role, it must rethink its internal governance and revamp its financing mechanisms.</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/rt08WP15xyM" height="1" width="1"/>]]></content:encoded>
<dc:title>The WHO must reform for its own health</dc:title>
<dc:creator>Tikki Pang</dc:creator>
<dc:creator>Laurie Garrett</dc:creator>
<dc:identifier>doi:10.1038/nm0512-646</dc:identifier>
<dc:source>Nature Medicine 18, 646 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm0512-646</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm0512-646</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News</prism:section>
<prism:startingPage>646</prism:startingPage>
<prism:endingPage>646</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm0512-646</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2751">
                     <title>Founding a new field</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/MU512Tx9-vo/nm.2751</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Founding a new field</b>
</p>
<p>Nature Medicine 18, 647 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2751">doi:10.1038/nm.2751</a>
</p>
<p>Author: David Nathan</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/MU512Tx9-vo" height="1" width="1"/>]]></content:encoded>
<dc:title>Founding a new field</dc:title>
<dc:creator>David Nathan</dc:creator>
<dc:identifier>doi:10.1038/nm.2751</dc:identifier>
<dc:source>Nature Medicine 18, 647 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2751</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2751</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Book Review</prism:section>
<prism:startingPage>647</prism:startingPage>
<prism:endingPage>647</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2751</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2733">
                     <title>Activation of BK channels may not be required for bitter tastant–induced bronchodilation</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/39rYtyWgGlo/nm.2733</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Activation of BK channels may not be required for bitter tastant&#8211;induced bronchodilation</b>
</p>
<p>Nature Medicine 18, 648 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2733">doi:10.1038/nm.2733</a>
</p>
<p>Authors: Cheng-Hai Zhang, Chen Chen, Lawrence M Lifshitz, Kevin E Fogarty, Min-Sheng Zhu &amp; Ronghua ZhuGe</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/39rYtyWgGlo" height="1" width="1"/>]]></content:encoded>
<dc:title>Activation of BK channels may not be required for bitter tastant–induced bronchodilation</dc:title>
<dc:creator>Cheng-Hai Zhang</dc:creator>
<dc:creator>Chen Chen</dc:creator>
<dc:creator>Lawrence M Lifshitz</dc:creator>
<dc:creator>Kevin E Fogarty</dc:creator>
<dc:creator>Min-Sheng Zhu</dc:creator>
<dc:creator>Ronghua ZhuGe</dc:creator>
<dc:identifier>doi:10.1038/nm.2733</dc:identifier>
<dc:source>Nature Medicine 18, 648 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2733</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2733</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Correspondence</prism:section>
<prism:startingPage>648</prism:startingPage>
<prism:endingPage>650</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2733</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2734">
                     <title>Reply to: TAS2R-activation of BKca is essential for maximal physiological response in human airway smooth muscle</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/L1txXZ0ZPag/nm.2734</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Reply to: TAS2R-activation of BKca is essential for maximal physiological response in human airway smooth muscle</b>
</p>
<p>Nature Medicine 18, 650 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2734">doi:10.1038/nm.2734</a>
</p>
<p>Authors: Steven S An, Kathryn S Robinett, Deepak A Deshpande, Wayne C H Wang &amp; Stephen B Liggett</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/L1txXZ0ZPag" height="1" width="1"/>]]></content:encoded>
<dc:title>Reply to: TAS2R-activation of BKca is essential for maximal physiological response in human airway smooth muscle</dc:title>
<dc:creator>Steven S An</dc:creator>
<dc:creator>Kathryn S Robinett</dc:creator>
<dc:creator>Deepak A Deshpande</dc:creator>
<dc:creator>Wayne C H Wang</dc:creator>
<dc:creator>Stephen B Liggett</dc:creator>
<dc:identifier>doi:10.1038/nm.2734</dc:identifier>
<dc:source>Nature Medicine 18, 650 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2734</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2734</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Correspondence</prism:section>
<prism:startingPage>650</prism:startingPage>
<prism:endingPage>651</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2734</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2769">
                     <title>Mitochondria to the rescue</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/5uc4ArMCafY/nm.2769</link>
<description>A new study using a mouse model of lung diseases is the first demonstration in vivo that bone marrow–derived stromal cells can repair tissue injury through the transfer of mitochondria (pages 759–765). This suggests that rescue of injured cells through mitochondrial transfer may be an important process in many diseases.</description>
<content:encoded><![CDATA[

<p>
<b>Mitochondria to the rescue</b>
</p>
<p>Nature Medicine 18, 653 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2769">doi:10.1038/nm.2769</a>
</p>
<p>Author: Darwin J Prockop</p>
<p>A new study using a mouse model of lung diseases is the first demonstration in vivo that bone marrow&#8211;derived stromal cells can repair tissue injury through the transfer of mitochondria (pages 759&#8211;765). This suggests that rescue of injured cells through mitochondrial transfer may be an important process in many diseases.</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/5uc4ArMCafY" height="1" width="1"/>]]></content:encoded>
<dc:title>Mitochondria to the rescue</dc:title>
<dc:creator>Darwin J Prockop</dc:creator>
<dc:identifier>doi:10.1038/nm.2769</dc:identifier>
<dc:source>Nature Medicine 18, 653 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2769</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2769</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News and Views</prism:section>
<prism:startingPage>653</prism:startingPage>
<prism:endingPage>654</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2769</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2767">
                     <title>Germs gone wild</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/931IN3sbuy4/nm.2767</link>
<description>The normally harmless behavior of bacteria in the intestinal tract is maintained by community structure and the integrity of host defenses. When either or both of these are compromised, a few disgruntled outcasts can cause a riot, taking down the whole neighborhood (pages 799–806).</description>
<content:encoded><![CDATA[

<p>
<b>Germs gone wild</b>
</p>
<p>Nature Medicine 18, 654 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2767">doi:10.1038/nm.2767</a>
</p>
<p>Authors: Namiko Hoshi &amp; Ruslan Medzhitov</p>
<p>The normally harmless behavior of bacteria in the intestinal tract is maintained by community structure and the integrity of host defenses. When either or both of these are compromised, a few disgruntled outcasts can cause a riot, taking down the whole neighborhood (pages 799&#8211;806).</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/931IN3sbuy4" height="1" width="1"/>]]></content:encoded>
<dc:title>Germs gone wild</dc:title>
<dc:creator>Namiko Hoshi</dc:creator>
<dc:creator>Ruslan Medzhitov</dc:creator>
<dc:identifier>doi:10.1038/nm.2767</dc:identifier>
<dc:source>Nature Medicine 18, 654 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2767</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2767</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News and Views</prism:section>
<prism:startingPage>654</prism:startingPage>
<prism:endingPage>656</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2767</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2773">
                     <title>Metabolic surgery for type 2 diabetes</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/2S7FrUDgXwA/nm.2773</link>
<description>Clinicians note that bariatric operations can dramatically resolve type 2 diabetes, often before and out of proportion to postoperative weight loss. Now two randomized controlled trials formally show superior results from surgical compared with medical diabetes care, including among only mildly obese patients. The concept of 'metabolic surgery' to treat diabetes has taken a big step forward.</description>
<content:encoded><![CDATA[

<p>
<b>Metabolic surgery for type 2 diabetes</b>
</p>
<p>Nature Medicine 18, 656 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2773">doi:10.1038/nm.2773</a>
</p>
<p>Author: David E Cummings</p>
<p>Clinicians note that bariatric operations can dramatically resolve type 2 diabetes, often before and out of proportion to postoperative weight loss. Now two randomized controlled trials formally show superior results from surgical compared with medical diabetes care, including among only mildly obese patients. The concept of 'metabolic surgery' to treat diabetes has taken a big step forward.</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/2S7FrUDgXwA" height="1" width="1"/>]]></content:encoded>
<dc:title>Metabolic surgery for type 2 diabetes</dc:title>
<dc:creator>David E Cummings</dc:creator>
<dc:identifier>doi:10.1038/nm.2773</dc:identifier>
<dc:source>Nature Medicine 18, 656 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2773</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2773</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News and Views</prism:section>
<prism:startingPage>656</prism:startingPage>
<prism:endingPage>658</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2773</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2761">
                     <title>Protective inflammasome activation in AMD</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/LszmM5PPW88/nm.2761</link>
<description>Age-related macular degeneration (AMD) is the most common cause of blindness in the elderly. AMD progression is associated with alterations in inflammatory pathways and the immune system. A new study identifies a protective role for inflammasomes in AMD, suggesting that inflammasome activation might be manipulated as a potential therapeutic strategy for this condition (pages 791–798).</description>
<content:encoded><![CDATA[

<p>
<b>Protective inflammasome activation in AMD</b>
</p>
<p>Nature Medicine 18, 658 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2761">doi:10.1038/nm.2761</a>
</p>
<p>Authors: Jing Chen &amp; Lois E H Smith</p>
<p>Age-related macular degeneration (AMD) is the most common cause of blindness in the elderly. AMD progression is associated with alterations in inflammatory pathways and the immune system. A new study identifies a protective role for inflammasomes in AMD, suggesting that inflammasome activation might be manipulated as a potential therapeutic strategy for this condition (pages 791&#8211;798).</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/LszmM5PPW88" height="1" width="1"/>]]></content:encoded>
<dc:title>Protective inflammasome activation in AMD</dc:title>
<dc:creator>Jing Chen</dc:creator>
<dc:creator>Lois E H Smith</dc:creator>
<dc:identifier>doi:10.1038/nm.2761</dc:identifier>
<dc:source>Nature Medicine 18, 658 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2761</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2761</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News and Views</prism:section>
<prism:startingPage>658</prism:startingPage>
<prism:endingPage>660</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2761</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2762">
                     <title>King of hearts: a splicing factor rules cardiac proteins</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/9ZPxj3z2Wxk/nm.2762</link>
<description>Alternative splicing ensures the expression of functionally diverse proteins from individual genes; however, aberrant mRNA splicing is associated with various conditions, including heart disease. A recent study provides new mechanistic insights into heart failure by showing that a human cardiomyopathy-linked mutation in a cardiac splice factor affects post-transcriptional regulation, causing the expression of anomalous isoforms of a whole network of cardiac proteins (pages 766–773).</description>
<content:encoded><![CDATA[

<p>
<b>King of hearts: a splicing factor rules cardiac proteins</b>
</p>
<p>Nature Medicine 18, 660 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2762">doi:10.1038/nm.2762</a>
</p>
<p>Authors: Wolfgang A Linke &amp; Sandra B&#252;cker</p>
<p>Alternative splicing ensures the expression of functionally diverse proteins from individual genes; however, aberrant mRNA splicing is associated with various conditions, including heart disease. A recent study provides new mechanistic insights into heart failure by showing that a human cardiomyopathy-linked mutation in a cardiac splice factor affects post-transcriptional regulation, causing the expression of anomalous isoforms of a whole network of cardiac proteins (pages 766&#8211;773).</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/9ZPxj3z2Wxk" height="1" width="1"/>]]></content:encoded>
<dc:title>King of hearts: a splicing factor rules cardiac proteins</dc:title>
<dc:creator>Wolfgang A Linke</dc:creator>
<dc:creator>Sandra Bücker</dc:creator>
<dc:identifier>doi:10.1038/nm.2762</dc:identifier>
<dc:source>Nature Medicine 18, 660 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2762</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2762</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News and Views</prism:section>
<prism:startingPage>660</prism:startingPage>
<prism:endingPage>661</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2762</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2765">
                     <title>Horizontal gene transfer boosts MRSA spreading</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/odavjyPOak8/nm.2765</link>
<description>Mechanisms triggering methicillin-resistant Staphylococcus aureus (MRSA) epidemics are poorly understood. A recent study provides new evidence that horizontal gene transfer may be the culprit for the emergence of new resistant and virulent MRSA clones.</description>
<content:encoded><![CDATA[

<p>
<b>Horizontal gene transfer boosts MRSA spreading</b>
</p>
<p>Nature Medicine 18, 662 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2765">doi:10.1038/nm.2765</a>
</p>
<p>Authors: Andr&#233; Kriegeskorte &amp; Georg Peters</p>
<p>Mechanisms triggering methicillin-resistant Staphylococcus aureus (MRSA) epidemics are poorly understood. A recent study provides new evidence that horizontal gene transfer may be the culprit for the emergence of new resistant and virulent MRSA clones.</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/odavjyPOak8" height="1" width="1"/>]]></content:encoded>
<dc:title>Horizontal gene transfer boosts MRSA spreading</dc:title>
<dc:creator>André Kriegeskorte</dc:creator>
<dc:creator>Georg Peters</dc:creator>
<dc:identifier>doi:10.1038/nm.2765</dc:identifier>
<dc:source>Nature Medicine 18, 662 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2765</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2765</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>News and Views</prism:section>
<prism:startingPage>662</prism:startingPage>
<prism:endingPage>663</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2765</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2770">
                     <title>A step closer to effective transplant tolerance?</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/W8SOsvTUKBk/nm.2770</link>
<description />
<content:encoded><![CDATA[

<p>
<b>A step closer to effective transplant tolerance?</b>
</p>
<p>Nature Medicine 18, 664 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2770">doi:10.1038/nm.2770</a>
</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/W8SOsvTUKBk" height="1" width="1"/>]]></content:encoded>
<dc:title>A step closer to effective transplant tolerance?</dc:title>
<dc:identifier>doi:10.1038/nm.2770</dc:identifier>
<dc:source>Nature Medicine 18, 664 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2770</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2770</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Community Corner</prism:section>
<prism:startingPage>664</prism:startingPage>
<prism:endingPage>665</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2770</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2747">
                     <title>Topic: Guts over glory—why diets fail</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/ETVHXa2fy98/nm.2747</link>
<description>Losing weight can pose a challenge, but how to avoid putting those pounds back on can be a real struggle. A major health problem for obese people is that diseases linked to obesity, such as type 2 diabetes and cardiovascular disease, put their lives at risk, even in young individuals. Although bariatric surgery—a surgical method to reduce or modify the gastrointestinal tract—was originally envisioned for the most severe cases of obesity, evidence suggests that the benefit of this procedure may not be limited to the staggering weight loss it causes. Endogenous factors released from the gut, and modified after surgery, may explain why bariatric surgery can be beneficial for obesity-related diseases and why operated individuals successfully maintain the weight loss. In 'Bedside to Bench,' Rachel Larder and Stephen O'Rahilly peruse a human study with dieters who regained weight despite a successful diet. Appetite-regulating hormones in the gut may be responsible for this relapse in the long term. In 'Bench to Bedside,' Keval Chandarana and Rachel Batterham examine how two different methods of bariatric surgery highlight the relevance of gut-derived hormones not only in inducing sustained weight loss but also in improving glucose homeostasis. These insights may open new avenues to bypass the surgery and obtain the same results with targeted drugs.</description>
<content:encoded><![CDATA[

<p>
<b>Topic: Guts over glory&#8212;why diets fail</b>
</p>
<p>Nature Medicine 18, 666 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2747">doi:10.1038/nm.2747</a>
</p>
<p>Authors: Rachel Larder &amp; Stephen O'Rahilly</p>
<p>Losing weight can pose a challenge, but how to avoid putting those pounds back on can be a real struggle. A major health problem for obese people is that diseases linked to obesity, such as type 2 diabetes and cardiovascular disease, put their lives at risk, even in young individuals. Although bariatric surgery&#8212;a surgical method to reduce or modify the gastrointestinal tract&#8212;was originally envisioned for the most severe cases of obesity, evidence suggests that the benefit of this procedure may not be limited to the staggering weight loss it causes. Endogenous factors released from the gut, and modified after surgery, may explain why bariatric surgery can be beneficial for obesity-related diseases and why operated individuals successfully maintain the weight loss. In 'Bedside to Bench,' Rachel Larder and Stephen O'Rahilly peruse a human study with dieters who regained weight despite a successful diet. Appetite-regulating hormones in the gut may be responsible for this relapse in the long term. In 'Bench to Bedside,' Keval Chandarana and Rachel Batterham examine how two different methods of bariatric surgery highlight the relevance of gut-derived hormones not only in inducing sustained weight loss but also in improving glucose homeostasis. These insights may open new avenues to bypass the surgery and obtain the same results with targeted drugs.</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/ETVHXa2fy98" height="1" width="1"/>]]></content:encoded>
<dc:title>Topic: Guts over glory—why diets fail</dc:title>
<dc:creator>Rachel Larder</dc:creator>
<dc:creator>Stephen O'Rahilly</dc:creator>
<dc:identifier>doi:10.1038/nm.2747</dc:identifier>
<dc:source>Nature Medicine 18, 666 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2747</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2747</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Between Bedside and Bench </prism:section>
<prism:startingPage>666</prism:startingPage>
<prism:endingPage>667</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2747</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2748">
                     <title>Topic: Metabolic insights from cutting the gut</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/Y49Lxsa1HMc/nm.2748</link>
<description>Losing weight can pose a challenge, but how to avoid putting those pounds back on can be a real struggle. A major health problem for obese people is that diseases linked to obesity, such as type 2 diabetes and cardiovascular disease, put their lives at risk, even in young individuals. Although bariatric surgery—a surgical method to reduce or modify the gastrointestinal tract—was originally envisioned for the most severe cases of obesity, evidence suggests that the benefit of this procedure may not be limited to the staggering weight loss it causes. Endogenous factors released from the gut, and modified after surgery, may explain why bariatric surgery can be beneficial for obesity-related diseases and why operated individuals successfully maintain the weight loss. In 'Bedside to Bench,' Rachel Larder and Stephen O'Rahilly peruse a human study with dieters who regained weight despite a successful diet. Appetite-regulating hormones in the gut may be responsible for this relapse in the long term. In 'Bench to Bedside,' Keval Chandarana and Rachel Batterham examine how two different methods of bariatric surgery highlight the relevance of gut-derived hormones not only in inducing sustained weight loss but also in improving glucose homeostasis. These insights may open new avenues to bypass the surgery and obtain the same results with targeted drugs.</description>
<content:encoded><![CDATA[

<p>
<b>Topic: Metabolic insights from cutting the gut</b>
</p>
<p>Nature Medicine 18, 668 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2748">doi:10.1038/nm.2748</a>
</p>
<p>Authors: Keval Chandarana &amp; Rachel L Batterham</p>
<p>Losing weight can pose a challenge, but how to avoid putting those pounds back on can be a real struggle. A major health problem for obese people is that diseases linked to obesity, such as type 2 diabetes and cardiovascular disease, put their lives at risk, even in young individuals. Although bariatric surgery&#8212;a surgical method to reduce or modify the gastrointestinal tract&#8212;was originally envisioned for the most severe cases of obesity, evidence suggests that the benefit of this procedure may not be limited to the staggering weight loss it causes. Endogenous factors released from the gut, and modified after surgery, may explain why bariatric surgery can be beneficial for obesity-related diseases and why operated individuals successfully maintain the weight loss. In 'Bedside to Bench,' Rachel Larder and Stephen O'Rahilly peruse a human study with dieters who regained weight despite a successful diet. Appetite-regulating hormones in the gut may be responsible for this relapse in the long term. In 'Bench to Bedside,' Keval Chandarana and Rachel Batterham examine how two different methods of bariatric surgery highlight the relevance of gut-derived hormones not only in inducing sustained weight loss but also in improving glucose homeostasis. These insights may open new avenues to bypass the surgery and obtain the same results with targeted drugs.</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/Y49Lxsa1HMc" height="1" width="1"/>]]></content:encoded>
<dc:title>Topic: Metabolic insights from cutting the gut</dc:title>
<dc:creator>Keval Chandarana</dc:creator>
<dc:creator>Rachel L Batterham</dc:creator>
<dc:identifier>doi:10.1038/nm.2748</dc:identifier>
<dc:source>Nature Medicine 18, 668 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2748</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2748</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Between Bedside and Bench </prism:section>
<prism:startingPage>668</prism:startingPage>
<prism:endingPage>669</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2748</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2781">
                     <title>Metabolism: Calcium-mediated control</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/1t8IHIZR5Vo/nm.2781</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Metabolism: Calcium-mediated control</b>
</p>
<p>Nature Medicine 18, 670 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2781">doi:10.1038/nm.2781</a>
</p>
<p>Author: Meera Swami</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/1t8IHIZR5Vo" height="1" width="1"/>]]></content:encoded>
<dc:title>Metabolism: Calcium-mediated control</dc:title>
<dc:creator>Meera Swami</dc:creator>
<dc:identifier>doi:10.1038/nm.2781</dc:identifier>
<dc:source>Nature Medicine 18, 670 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2781</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2781</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>670</prism:startingPage>
<prism:endingPage>670</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2781</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2783">
                     <title>Brain: Bouncing back after brain injury</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/tVMrJN3w6HM/nm.2783</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Brain: Bouncing back after brain injury</b>
</p>
<p>Nature Medicine 18, 670 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2783">doi:10.1038/nm.2783</a>
</p>
<p>Author: Eva Chmielnicki</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/tVMrJN3w6HM" height="1" width="1"/>]]></content:encoded>
<dc:title>Brain: Bouncing back after brain injury</dc:title>
<dc:creator>Eva Chmielnicki</dc:creator>
<dc:identifier>doi:10.1038/nm.2783</dc:identifier>
<dc:source>Nature Medicine 18, 670 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2783</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2783</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>670</prism:startingPage>
<prism:endingPage>670</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2783</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2785">
                     <title>Cardiovascular disease: Lipoprotein traffic control</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/Q58Uw7JnuE8/nm.2785</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Cardiovascular disease: Lipoprotein traffic control</b>
</p>
<p>Nature Medicine 18, 670 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2785">doi:10.1038/nm.2785</a>
</p>
<p>Author: Michael Basson</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/Q58Uw7JnuE8" height="1" width="1"/>]]></content:encoded>
<dc:title>Cardiovascular disease: Lipoprotein traffic control</dc:title>
<dc:creator>Michael Basson</dc:creator>
<dc:identifier>doi:10.1038/nm.2785</dc:identifier>
<dc:source>Nature Medicine 18, 670 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2785</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2785</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>670</prism:startingPage>
<prism:endingPage>670</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2785</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2779">
                     <title>Bone: Repairing joints</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/bBuW_oNsx14/nm.2779</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Bone: Repairing joints</b>
</p>
<p>Nature Medicine 18, 670 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2779">doi:10.1038/nm.2779</a>
</p>
<p>Author: Alison Farrell</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/bBuW_oNsx14" height="1" width="1"/>]]></content:encoded>
<dc:title>Bone: Repairing joints</dc:title>
<dc:creator>Alison Farrell</dc:creator>
<dc:identifier>doi:10.1038/nm.2779</dc:identifier>
<dc:source>Nature Medicine 18, 670 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2779</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2779</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>670</prism:startingPage>
<prism:endingPage>671</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2779</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2787">
                     <title>Immunology: Targeting IL-17 in psoriasis</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/kje4oxDtepw/nm.2787</link>
<description />
<content:encoded><![CDATA[

<p>
<b>Immunology: Targeting IL-17 in psoriasis</b>
</p>
<p>Nature Medicine 18, 671 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2787">doi:10.1038/nm.2787</a>
</p>
<p>Author: Juan Carlos L&#243;pez</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/kje4oxDtepw" height="1" width="1"/>]]></content:encoded>
<dc:title>Immunology: Targeting IL-17 in psoriasis</dc:title>
<dc:creator>Juan Carlos López</dc:creator>
<dc:identifier>doi:10.1038/nm.2787</dc:identifier>
<dc:source>Nature Medicine 18, 671 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2787</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2787</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>671</prism:startingPage>
<prism:endingPage>671</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2787</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2789">
                     <title>New from NPG</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/U8aV7CYpv6I/nm.2789</link>
<description />
<content:encoded><![CDATA[

<p>
<b>New from NPG</b>
</p>
<p>Nature Medicine 18, 671 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2789">doi:10.1038/nm.2789</a>
</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/U8aV7CYpv6I" height="1" width="1"/>]]></content:encoded>
<dc:title>New from NPG</dc:title>
<dc:identifier>doi:10.1038/nm.2789</dc:identifier>
<dc:source>Nature Medicine 18, 671 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2789</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2789</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Research Highlights</prism:section>
<prism:startingPage>671</prism:startingPage>
<prism:endingPage>671</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2789</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2731">
                     <title>Innate and adaptive immune responses in asthma</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/TvkDN-WagBs/nm.2731</link>
<description>Allergen sensitization is triggered by activating receptors of the innate arm of the immune system. This leads to the recruitment and activation of dendritic cells, which have a sentinel role in orchestrating the attendant adaptive response. Stephen Holgate highlights recent findings on how innate receptors are triggered, cellular sources of cytokines driving immune cell activation and the identification of new helper T cell subsets driving chronic allergic airway inflammation.</description>
<content:encoded><![CDATA[

<p>
<b>Innate and adaptive immune responses in asthma</b>
</p>
<p>Nature Medicine 18, 673 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2731">doi:10.1038/nm.2731</a>
</p>
<p>Author: Stephen T Holgate</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/TvkDN-WagBs" height="1" width="1"/>]]></content:encoded>
<dc:title>Innate and adaptive immune responses in asthma</dc:title>
<dc:creator>Stephen T Holgate</dc:creator>
<dc:identifier>doi:10.1038/nm.2731</dc:identifier>
<dc:source>Nature Medicine 18, 673 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2731</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2731</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>673</prism:startingPage>
<prism:endingPage>683</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2731</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2737">
                     <title>The airway epithelium in asthma</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/c5pq1v5tXuA/nm.2737</link>
<description>The airway epithelium has a sentinel role in initiating allergic responses and asthma. Bart Lambrecht and Hamida Hammad review recent findings on how allergens activate epithelial cells and induce the production of cytokines and chemokines that recruit and activate dendritic cells and other cells of the innate immune system. Activation of these cell types promotes adaptive immune responses, which are, the authors argue, further maintained and perpetuated by their interaction with airway epithelial cells.</description>
<content:encoded><![CDATA[

<p>
<b>The airway epithelium in asthma</b>
</p>
<p>Nature Medicine 18, 684 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2737">doi:10.1038/nm.2737</a>
</p>
<p>Authors: Bart N Lambrecht &amp; Hamida Hammad</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/c5pq1v5tXuA" height="1" width="1"/>]]></content:encoded>
<dc:title>The airway epithelium in asthma</dc:title>
<dc:creator>Bart N Lambrecht</dc:creator>
<dc:creator>Hamida Hammad</dc:creator>
<dc:identifier>doi:10.1038/nm.2737</dc:identifier>
<dc:source>Nature Medicine 18, 684 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2737</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2737</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>684</prism:startingPage>
<prism:endingPage>692</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2737</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2755">
                     <title>IgE and mast cells in allergic disease</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/rnRA6hIFS68/nm.2755</link>
<description>Both mast cells and IgE play crucial parts during the initiation and amplification of the allergic response during asthma, as well as during the tissue remodeling that occurs at the chronic stage. This review discusses how these two players can affect the development of asthma through independent and interdependent functions and the therapeutic implications for treating the clinical symptoms derived from allergic disease.</description>
<content:encoded><![CDATA[

<p>
<b>IgE and mast cells in allergic disease</b>
</p>
<p>Nature Medicine 18, 693 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2755">doi:10.1038/nm.2755</a>
</p>
<p>Authors: Stephen J Galli &amp; Mindy Tsai</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/rnRA6hIFS68" height="1" width="1"/>]]></content:encoded>
<dc:title>IgE and mast cells in allergic disease</dc:title>
<dc:creator>Stephen J Galli</dc:creator>
<dc:creator>Mindy Tsai</dc:creator>
<dc:identifier>doi:10.1038/nm.2755</dc:identifier>
<dc:source>Nature Medicine 18, 693 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2755</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2755</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>693</prism:startingPage>
<prism:endingPage>704</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2755</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2760">
                     <title>T cell homing to epithelial barriers in allergic disease</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/-fa7s7WybxE/nm.2760</link>
<description>Efficient trafficking of lymphocytes between the blood, lymphoid organs and peripheral tissues is essential for an effective immune response. Sabina Islam and Andrew Luster summarize recent findings on the regulation of leukocyte homing to the lungs, gut and skin in allergic inflammation and how leukocyte trafficking can be targeted clinically.</description>
<content:encoded><![CDATA[

<p>
<b>T cell homing to epithelial barriers in allergic disease</b>
</p>
<p>Nature Medicine 18, 705 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2760">doi:10.1038/nm.2760</a>
</p>
<p>Authors: Sabina A Islam &amp; Andrew D Luster</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/-fa7s7WybxE" height="1" width="1"/>]]></content:encoded>
<dc:title>T cell homing to epithelial barriers in allergic disease</dc:title>
<dc:creator>Sabina A Islam</dc:creator>
<dc:creator>Andrew D Luster</dc:creator>
<dc:identifier>doi:10.1038/nm.2760</dc:identifier>
<dc:source>Nature Medicine 18, 705 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2760</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2760</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>705</prism:startingPage>
<prism:endingPage>715</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2760</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2678">
                     <title>Asthma phenotypes: the evolution from clinical to molecular approaches</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/JvG2LXPFwfE/nm.2678</link>
<description>The growing appreciation of asthma as a heterogeneous disease has led to the concept that asthma consists of multiple, different phenotypes, but now the challenge is to link underlying biology to phenotypes to allow a more robust classification and understanding of asthma. This review discusses the progress in defining asthma phenotypes and provides insights into how to apply this knowledge to provide more personalized approaches to treating asthma.</description>
<content:encoded><![CDATA[

<p>
<b>Asthma phenotypes: the evolution from clinical to molecular approaches</b>
</p>
<p>Nature Medicine 18, 716 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2678">doi:10.1038/nm.2678</a>
</p>
<p>Author: Sally E Wenzel</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/JvG2LXPFwfE" height="1" width="1"/>]]></content:encoded>
<dc:title>Asthma phenotypes: the evolution from clinical to molecular approaches</dc:title>
<dc:creator>Sally E Wenzel</dc:creator>
<dc:identifier>doi:10.1038/nm.2678</dc:identifier>
<dc:source>Nature Medicine 18, 716 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2678</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2678</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>716</prism:startingPage>
<prism:endingPage>725</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2678</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2768">
                     <title>Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/kWKhe10R9Es/nm.2768</link>
<description>Viral infections can worsen episodes of allergic sensitization to allergens, putting the affected individuals, often children, at risk for developing persistent asthma during adult life. Understanding how the mechanisms mediating the antiviral response and driving allergic inflammation caused by allergens interact is crucial. This will provide insights into when and what player or molecule to target for treatment and prevention of asthma in children at the early stages of the disease.</description>
<content:encoded><![CDATA[

<p>
<b>Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment</b>
</p>
<p>Nature Medicine 18, 726 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2768">doi:10.1038/nm.2768</a>
</p>
<p>Authors: Patrick G Holt &amp; Peter D Sly</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/kWKhe10R9Es" height="1" width="1"/>]]></content:encoded>
<dc:title>Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment</dc:title>
<dc:creator>Patrick G Holt</dc:creator>
<dc:creator>Peter D Sly</dc:creator>
<dc:identifier>doi:10.1038/nm.2768</dc:identifier>
<dc:source>Nature Medicine 18, 726 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2768</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2768</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>726</prism:startingPage>
<prism:endingPage>735</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2768</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2754">
                     <title>Therapies for allergic inflammation: refining strategies to induce tolerance</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/gahIBj8LHP4/nm.2754</link>
<description>This review outlines recent advances in the development of therapeutics that induce immune tolerance to treat asthma and allergic disease. It focuses on the distinct approaches of allergen-specific immunotherapy and biological immune modifiers and also highlights the possibility of combining these two strategies to harness the advantages of both types of therapy and address current unmet clinical needs associated with these conditions.</description>
<content:encoded><![CDATA[

<p>
<b>Therapies for allergic inflammation: refining strategies to induce tolerance</b>
</p>
<p>Nature Medicine 18, 736 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2754">doi:10.1038/nm.2754</a>
</p>
<p>Author: Cezmi A Akdis</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/gahIBj8LHP4" height="1" width="1"/>]]></content:encoded>
<dc:title>Therapies for allergic inflammation: refining strategies to induce tolerance</dc:title>
<dc:creator>Cezmi A Akdis</dc:creator>
<dc:identifier>doi:10.1038/nm.2754</dc:identifier>
<dc:source>Nature Medicine 18, 736 (2012)</dc:source>
<dc:date>2012-05-04</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-05-04</prism:publicationDate>
<prism:doi>10.1038/nm.2754</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2754</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Review</prism:section>
<prism:startingPage>736</prism:startingPage>
<prism:endingPage>749</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2754</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2735">
                     <title>Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/u1MIF8MA79o/nm.2735</link>
<description>Interleukin-25 (IL-25) is released from lung epithelial cells in response to allergen challenge and promotes type 2 immune responses and allergic airway inflammation. Nicholas Lukacs and his colleagues now report that IL-25 acts on a myeloid population in the lung. These cells represent a major source of IL-4 and IL-13, promote allergic lung inflammation and are steroid resistant. The frequency of IL-4– and IL-13–producing myeloid cells is increased in individuals with asthma, suggesting these cells may have a crucial role in the development of asthma.</description>
<content:encoded><![CDATA[

<p>
<b>Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology</b>
</p>
<p>Nature Medicine 18, 751 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2735">doi:10.1038/nm.2735</a>
</p>
<p>Authors: Bryan C Petersen, Alison L Budelsky, Alan P Baptist, Matthew A Schaller &amp; Nicholas W Lukacs</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/u1MIF8MA79o" height="1" width="1"/>]]></content:encoded>
<dc:title>Interleukin-25 induces type 2 cytokine production in a steroid-resistant interleukin-17RB+ myeloid population that exacerbates asthmatic pathology</dc:title>
<dc:creator>Bryan C Petersen</dc:creator>
<dc:creator>Alison L Budelsky</dc:creator>
<dc:creator>Alan P Baptist</dc:creator>
<dc:creator>Matthew A Schaller</dc:creator>
<dc:creator>Nicholas W Lukacs</dc:creator>
<dc:identifier>doi:10.1038/nm.2735</dc:identifier>
<dc:source>Nature Medicine 18, 751 (2012)</dc:source>
<dc:date>2012-04-29</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-04-29</prism:publicationDate>
<prism:doi>10.1038/nm.2735</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2735</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Article</prism:section>
<prism:startingPage>751</prism:startingPage>
<prism:endingPage>758</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2735</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2736">
                     <title>Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/WSMSjc5gdxQ/nm.2736</link>
<description>Bone-marrow–derived stromal cells are known to protect against acute lung injury. Jahar Bhattacharya and colleagues now show that one way these cells offer such protection is to transfer their mitochondria to the injured lung epithelia to improve the bioenergetics of the recipient cells, thus probably allowing them to recover from injury more efficiently.</description>
<content:encoded><![CDATA[

<p>
<b>Mitochondrial transfer from bone-marrow&#8211;derived stromal cells to pulmonary alveoli protects against acute lung injury</b>
</p>
<p>Nature Medicine 18, 759 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2736">doi:10.1038/nm.2736</a>
</p>
<p>Authors: Mohammad Naimul Islam, Shonit R Das, Memet T Emin, Michelle Wei, Li Sun, Kristin Westphalen, David J Rowlands, Sadiqa K Quadri, Sunita Bhattacharya &amp; Jahar Bhattacharya</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/WSMSjc5gdxQ" height="1" width="1"/>]]></content:encoded>
<dc:title>Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury</dc:title>
<dc:creator>Mohammad Naimul Islam</dc:creator>
<dc:creator>Shonit R Das</dc:creator>
<dc:creator>Memet T Emin</dc:creator>
<dc:creator>Michelle Wei</dc:creator>
<dc:creator>Li Sun</dc:creator>
<dc:creator>Kristin Westphalen</dc:creator>
<dc:creator>David J Rowlands</dc:creator>
<dc:creator>Sadiqa K Quadri</dc:creator>
<dc:creator>Sunita Bhattacharya</dc:creator>
<dc:creator>Jahar Bhattacharya</dc:creator>
<dc:identifier>doi:10.1038/nm.2736</dc:identifier>
<dc:source>Nature Medicine 18, 759 (2012)</dc:source>
<dc:date>2012-04-15</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-04-15</prism:publicationDate>
<prism:doi>10.1038/nm.2736</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2736</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Article</prism:section>
<prism:startingPage>759</prism:startingPage>
<prism:endingPage>765</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2736</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2693">
                     <title>RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/HKinBcilX-g/nm.2693</link>
<description>Alternative splicing affects the function of many cardiac proteins, including that of the sarcomeric protein titin. Wei Guo et al. now show that the gene RBM20, previously identified as mutated in some individuals with dilated cardiomyopathy, is a splicing factor that regulates the alternative splicing of the gene encoding titin and many other key cardiac genes.</description>
<content:encoded><![CDATA[

<p>
<b>RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing</b>
</p>
<p>Nature Medicine 18, 766 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2693">doi:10.1038/nm.2693</a>
</p>
<p>Authors: Wei Guo, Sebastian Schafer, Marion L Greaser, Michael H Radke, Martin Liss, Thirupugal Govindarajan, Henrike Maatz, Herbert Schulz, Shijun Li, Amanda M Parrish, Vita Dauksaite, Padmanabhan Vakeel, Sabine Klaassen, Brenda Gerull, Ludwig Thierfelder, Vera Regitz-Zagrosek, Timothy A Hacker, Kurt W Saupe, G William Dec, Patrick T Ellinor, Calum A MacRae, Bastian Spallek, Robert Fischer, Andreas Perrot, Cemil &#214;zcelik, Kathrin Saar, Norbert Hubner &amp; Michael Gotthardt</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/HKinBcilX-g" height="1" width="1"/>]]></content:encoded>
<dc:title>RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing</dc:title>
<dc:creator>Wei Guo</dc:creator>
<dc:creator>Sebastian Schafer</dc:creator>
<dc:creator>Marion L Greaser</dc:creator>
<dc:creator>Michael H Radke</dc:creator>
<dc:creator>Martin Liss</dc:creator>
<dc:creator>Thirupugal Govindarajan</dc:creator>
<dc:creator>Henrike Maatz</dc:creator>
<dc:creator>Herbert Schulz</dc:creator>
<dc:creator>Shijun Li</dc:creator>
<dc:creator>Amanda M Parrish</dc:creator>
<dc:creator>Vita Dauksaite</dc:creator>
<dc:creator>Padmanabhan Vakeel</dc:creator>
<dc:creator>Sabine Klaassen</dc:creator>
<dc:creator>Brenda Gerull</dc:creator>
<dc:creator>Ludwig Thierfelder</dc:creator>
<dc:creator>Vera Regitz-Zagrosek</dc:creator>
<dc:creator>Timothy A Hacker</dc:creator>
<dc:creator>Kurt W Saupe</dc:creator>
<dc:creator>G William Dec</dc:creator>
<dc:creator>Patrick T Ellinor</dc:creator>
<dc:creator>Calum A MacRae</dc:creator>
<dc:creator>Bastian Spallek</dc:creator>
<dc:creator>Robert Fischer</dc:creator>
<dc:creator>Andreas Perrot</dc:creator>
<dc:creator>Cemil Özcelik</dc:creator>
<dc:creator>Kathrin Saar</dc:creator>
<dc:creator>Norbert Hubner</dc:creator>
<dc:creator>Michael Gotthardt</dc:creator>
<dc:identifier>doi:10.1038/nm.2693</dc:identifier>
<dc:source>Nature Medicine 18, 766 (2012)</dc:source>
<dc:date>2012-04-01</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-04-01</prism:publicationDate>
<prism:doi>10.1038/nm.2693</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2693</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Article</prism:section>
<prism:startingPage>766</prism:startingPage>
<prism:endingPage>773</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2693</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2728">
                     <title>Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/iPzPA5erxX8/nm.2728</link>
<description>Tobias Eckle et al. describe a new regulatory circuit in the heart by which adenosine receptor signaling controls expression of the circadian protein Per2, which stabilizes the transcription factor Hif-1α, promotes glycolytic metabolism and has cardioprotective effects. Exposing mice to intense light was able to stabilize Per2 in the heart and reduce cardiac injury after myocardial ischemia.</description>
<content:encoded><![CDATA[

<p>
<b>Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia</b>
</p>
<p>Nature Medicine 18, 774 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2728">doi:10.1038/nm.2728</a>
</p>
<p>Authors: Tobias Eckle, Katherine Hartmann, Stephanie Bonney, Susan Reithel, Michel Mittelbronn, Lori A Walker, Brian D Lowes, Jun Han, Christoph H Borchers, Peter M Buttrick, Douglas J Kominsky, Sean P Colgan &amp; Holger K Eltzschig</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/iPzPA5erxX8" height="1" width="1"/>]]></content:encoded>
<dc:title>Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia</dc:title>
<dc:creator>Tobias Eckle</dc:creator>
<dc:creator>Katherine Hartmann</dc:creator>
<dc:creator>Stephanie Bonney</dc:creator>
<dc:creator>Susan Reithel</dc:creator>
<dc:creator>Michel Mittelbronn</dc:creator>
<dc:creator>Lori A Walker</dc:creator>
<dc:creator>Brian D Lowes</dc:creator>
<dc:creator>Jun Han</dc:creator>
<dc:creator>Christoph H Borchers</dc:creator>
<dc:creator>Peter M Buttrick</dc:creator>
<dc:creator>Douglas J Kominsky</dc:creator>
<dc:creator>Sean P Colgan</dc:creator>
<dc:creator>Holger K Eltzschig</dc:creator>
<dc:identifier>doi:10.1038/nm.2728</dc:identifier>
<dc:source>Nature Medicine 18, 774 (2012)</dc:source>
<dc:date>2012-04-15</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-04-15</prism:publicationDate>
<prism:doi>10.1038/nm.2728</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2728</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Article</prism:section>
<prism:startingPage>774</prism:startingPage>
<prism:endingPage>782</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2728</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2709">
                     <title>Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/gdU3q_3zT38/nm.2709</link>
<description>Ataxia-telangiectasia is a multifaceted disease that includes motor dysfunction caused by neuron death in the cerebellum. Now, Karl Herrup and colleagues report that ATM, the gene that is lost in the disease, keeps HDAC4 out of the nucleus and in the cytoplasm to maintain cerebellar neuron health.</description>
<content:encoded><![CDATA[

<p>
<b>Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia</b>
</p>
<p>Nature Medicine 18, 783 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2709">doi:10.1038/nm.2709</a>
</p>
<p>Authors: Jiali Li, Jianmin Chen, Christopher L Ricupero, Ronald P Hart, Melanie S Schwartz, Alexander Kusnecov &amp; Karl Herrup</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/gdU3q_3zT38" height="1" width="1"/>]]></content:encoded>
<dc:title>Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia</dc:title>
<dc:creator>Jiali Li</dc:creator>
<dc:creator>Jianmin Chen</dc:creator>
<dc:creator>Christopher L Ricupero</dc:creator>
<dc:creator>Ronald P Hart</dc:creator>
<dc:creator>Melanie S Schwartz</dc:creator>
<dc:creator>Alexander Kusnecov</dc:creator>
<dc:creator>Karl Herrup</dc:creator>
<dc:identifier>doi:10.1038/nm.2709</dc:identifier>
<dc:source>Nature Medicine 18, 783 (2012)</dc:source>
<dc:date>2012-04-01</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-04-01</prism:publicationDate>
<prism:doi>10.1038/nm.2709</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2709</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Article</prism:section>
<prism:startingPage>783</prism:startingPage>
<prism:endingPage>790</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2709</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2717">
                     <title>NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/_HoUxf4deVI/nm.2717</link>
<description>Age-related macular degeneration is a blinding disease associated with accumulation of aggregates called drusen in the retina. Now, Matthew Campbell and colleagues show that drusen can activate the inflammasome and that this activation protects against disease progression.</description>
<content:encoded><![CDATA[

<p>
<b>NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components</b>
</p>
<p>Nature Medicine 18, 791 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2717">doi:10.1038/nm.2717</a>
</p>
<p>Authors: Sarah L Doyle, Matthew Campbell, Ema Ozaki, Robert G Salomon, Andres Mori, Paul F Kenna, Gwyneth Jane Farrar, Anna-Sophia Kiang, Marian M Humphries, Ed C Lavelle, Luke A J O'Neill, Joe G Hollyfield &amp; Peter Humphries</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/_HoUxf4deVI" height="1" width="1"/>]]></content:encoded>
<dc:title>NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components</dc:title>
<dc:creator>Sarah L Doyle</dc:creator>
<dc:creator>Matthew Campbell</dc:creator>
<dc:creator>Ema Ozaki</dc:creator>
<dc:creator>Robert G Salomon</dc:creator>
<dc:creator>Andres Mori</dc:creator>
<dc:creator>Paul F Kenna</dc:creator>
<dc:creator>Gwyneth Jane Farrar</dc:creator>
<dc:creator>Anna-Sophia Kiang</dc:creator>
<dc:creator>Marian M Humphries</dc:creator>
<dc:creator>Ed C Lavelle</dc:creator>
<dc:creator>Luke A J O'Neill</dc:creator>
<dc:creator>Joe G Hollyfield</dc:creator>
<dc:creator>Peter Humphries</dc:creator>
<dc:identifier>doi:10.1038/nm.2717</dc:identifier>
<dc:source>Nature Medicine 18, 791 (2012)</dc:source>
<dc:date>2012-04-08</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-04-08</prism:publicationDate>
<prism:doi>10.1038/nm.2717</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2717</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Article</prism:section>
<prism:startingPage>791</prism:startingPage>
<prism:endingPage>798</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2717</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2729">
                     <title>Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/25itUH5GUck/nm.2729</link>
<description>The maintenance of a normal intestinal microbiota is associated with gut integrity and healthy immune responses. In this issue, Janelle Ayres and her colleagues report that disruption of the gut microbiome with antibiotics, coupled with gut injury, leads to the outgrowth of a pathogenic commensal bacterium and a sepsis-like disease. Their results show that the Naip5-Nlrc4 inflammasome is crucial for sensing the pathobiont and is a key factor in triggering the disease phenotype.</description>
<content:encoded><![CDATA[

<p>
<b>Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota</b>
</p>
<p>Nature Medicine 18, 799 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2729">doi:10.1038/nm.2729</a>
</p>
<p>Authors: Janelle S Ayres, Norver J Trinidad &amp; Russell E Vance</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/25itUH5GUck" height="1" width="1"/>]]></content:encoded>
<dc:title>Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota</dc:title>
<dc:creator>Janelle S Ayres</dc:creator>
<dc:creator>Norver J Trinidad</dc:creator>
<dc:creator>Russell E Vance</dc:creator>
<dc:identifier>doi:10.1038/nm.2729</dc:identifier>
<dc:source>Nature Medicine 18, 799 (2012)</dc:source>
<dc:date>2012-04-22</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-04-22</prism:publicationDate>
<prism:doi>10.1038/nm.2729</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2729</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Article</prism:section>
<prism:startingPage>799</prism:startingPage>
<prism:endingPage>806</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2729</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2700">
                     <title>Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/9tuBZLVKGu8/nm.2700</link>
<description>Engineered T cells expressing a tumor antigen specific T cell receptor (TCR) have shown promise for cancer immunotherapy. However, the introduced TCR chains can pair with the endogenous TCR chains in T cells, and in mice, these mismatched TCRs can cause a lethal autoimmune reaction. Provasi et al. now show that they can eliminate expression of the endogenous TCR chains using zinc finger nucleases and express only the desired exogenous TCR by lentiviral transduction. The resultant TCR-edited lymphocytes showed tumor specificity without the risk of off-target toxicity.</description>
<content:encoded><![CDATA[

<p>
<b>Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer</b>
</p>
<p>Nature Medicine 18, 807 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2700">doi:10.1038/nm.2700</a>
</p>
<p>Authors: Elena Provasi, Pietro Genovese, Angelo Lombardo, Zulma Magnani, Pei-Qi Liu, Andreas Reik, Victoria Chu, David E Paschon, Lei Zhang, Jurgen Kuball, Barbara Camisa, Attilio Bondanza, Giulia Casorati, Maurilio Ponzoni, Fabio Ciceri, Claudio Bordignon, Philip D Greenberg, Michael C Holmes, Philip D Gregory, Luigi Naldini &amp; Chiara Bonini</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/9tuBZLVKGu8" height="1" width="1"/>]]></content:encoded>
<dc:title>Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer</dc:title>
<dc:creator>Elena Provasi</dc:creator>
<dc:creator>Pietro Genovese</dc:creator>
<dc:creator>Angelo Lombardo</dc:creator>
<dc:creator>Zulma Magnani</dc:creator>
<dc:creator>Pei-Qi Liu</dc:creator>
<dc:creator>Andreas Reik</dc:creator>
<dc:creator>Victoria Chu</dc:creator>
<dc:creator>David E Paschon</dc:creator>
<dc:creator>Lei Zhang</dc:creator>
<dc:creator>Jurgen Kuball</dc:creator>
<dc:creator>Barbara Camisa</dc:creator>
<dc:creator>Attilio Bondanza</dc:creator>
<dc:creator>Giulia Casorati</dc:creator>
<dc:creator>Maurilio Ponzoni</dc:creator>
<dc:creator>Fabio Ciceri</dc:creator>
<dc:creator>Claudio Bordignon</dc:creator>
<dc:creator>Philip D Greenberg</dc:creator>
<dc:creator>Michael C Holmes</dc:creator>
<dc:creator>Philip D Gregory</dc:creator>
<dc:creator>Luigi Naldini</dc:creator>
<dc:creator>Chiara Bonini</dc:creator>
<dc:identifier>doi:10.1038/nm.2700</dc:identifier>
<dc:source>Nature Medicine 18, 807 (2012)</dc:source>
<dc:date>2012-04-01</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-04-01</prism:publicationDate>
<prism:doi>10.1038/nm.2700</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2700</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Article</prism:section>
<prism:startingPage>807</prism:startingPage>
<prism:endingPage>815</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2700</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2692">
                     <title>MRSA epidemic linked to a quickly spreading colonization and virulence determinant</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/s1qM_-vEwEA/nm.2692</link>
<description>A mobile genetic element—sasX—has a key role in the pathogenesis of methicillin-resistant Staphylococcus aureus (MRSA) infection. This rapidly spreading determinant of MRSA pathogenic success markedly enhances nasal colonization, lung disease and immune evasion.</description>
<content:encoded><![CDATA[

<p>
<b>MRSA epidemic linked to a quickly spreading colonization and virulence determinant</b>
</p>
<p>Nature Medicine 18, 816 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2692">doi:10.1038/nm.2692</a>
</p>
<p>Authors: Min Li, Xin Du, Amer E Villaruz, Binh An Diep, Decheng Wang, Yan Song, Yueru Tian, Jinhui Hu, Fangyou Yu, Yuan Lu &amp; Michael Otto</p>
<p>The molecular processes underlying epidemic waves of methicillin-resistant Staphylococcus aureus (MRSA) infection are poorly understood. Although a major role has been attributed to the acquisition of virulence determinants by horizontal gene transfer, there are insufficient epidemiological and functional data supporting that concept. We here report the spread of clones containing a previously extremely rare mobile genetic element&#8211;encoded gene, sasX. We demonstrate that sasX has a key role in MRSA colonization and pathogenesis, substantially enhancing nasal colonization, lung disease and abscess formation and promoting mechanisms of immune evasion. Moreover, we observed the recent spread of sasX from sequence type 239 (ST239) to invasive clones belonging to other sequence types. Our study identifies sasX as a quickly spreading crucial determinant of MRSA pathogenic success and a promising target for therapeutic interference. Our results provide proof of principle that horizontal gene transfer of key virulence determinants drives MRSA epidemic waves.</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/s1qM_-vEwEA" height="1" width="1"/>]]></content:encoded>
<dc:title>MRSA epidemic linked to a quickly spreading colonization and virulence determinant</dc:title>
<dc:creator>Min Li</dc:creator>
<dc:creator>Xin Du</dc:creator>
<dc:creator>Amer E Villaruz</dc:creator>
<dc:creator>Binh An Diep</dc:creator>
<dc:creator>Decheng Wang</dc:creator>
<dc:creator>Yan Song</dc:creator>
<dc:creator>Yueru Tian</dc:creator>
<dc:creator>Jinhui Hu</dc:creator>
<dc:creator>Fangyou Yu</dc:creator>
<dc:creator>Yuan Lu</dc:creator>
<dc:creator>Michael Otto</dc:creator>
<dc:identifier>doi:10.1038/nm.2692</dc:identifier>
<dc:source>Nature Medicine 18, 816 (2012)</dc:source>
<dc:date>2012-04-22</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-04-22</prism:publicationDate>
<prism:doi>10.1038/nm.2692</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2692</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Letter</prism:section>
<prism:startingPage>816</prism:startingPage>
<prism:endingPage>819</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2692</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2724">
                     <title>Leptin action through hypothalamic nitric oxide synthase-1–expressing neurons controls energy balance</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/KPCw5r23y4c/nm.2724</link>
<description>The adipocyte-derived hormone leptin acts on the brain to signal the long-term status of energy balance in the body. Martin Myers and his colleagues narrow down the population of neurons in the brain that actuate leptin's effects on food intake, and thus systemic energy balance, to a relatively small percentage of Nos1+ cells in the hypothalamus.</description>
<content:encoded><![CDATA[

<p>
<b>Leptin action through hypothalamic nitric oxide synthase-1&#8211;expressing neurons controls energy balance</b>
</p>
<p>Nature Medicine 18, 820 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2724">doi:10.1038/nm.2724</a>
</p>
<p>Authors: Rebecca L Leshan, Megan Greenwald-Yarnell, Christa M Patterson, Ian E Gonzalez &amp; Martin G Myers</p>
<p>Few effective measures exist to combat the worldwide obesity epidemic, and the identification of potential therapeutic targets requires a deeper understanding of the mechanisms that control energy balance. Leptin, an adipocyte-derived hormone that signals the long-term status of bodily energy stores, acts through multiple types of leptin receptor long isoform (LepRb)-expressing neurons (called here LepRb neurons) in the brain to control feeding, energy expenditure and endocrine function. The modest contributions to energy balance that are attributable to leptin action in many LepRb populations suggest that other previously unidentified hypothalamic LepRb neurons have key roles in energy balance. Here we examine the role of LepRb in neuronal nitric oxide synthase (NOS1)-expressing LebRb (LepRbNOS1) neurons that comprise approximately 20% of the total hypothalamic LepRb neurons. Nos1cre-mediated genetic ablation of LepRb (LeprNos1KO) in mice produces hyperphagic obesity, decreased energy expenditure and hyperglycemia approaching that seen in whole-body LepRb-null mice. In contrast, the endocrine functions in LeprNos1KO mice are only modestly affected by the genetic ablation of LepRb in these neurons. Thus, hypothalamic LepRbNOS1 neurons are a key site of action of the leptin-mediated control of systemic energy balance.</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/KPCw5r23y4c" height="1" width="1"/>]]></content:encoded>
<dc:title>Leptin action through hypothalamic nitric oxide synthase-1–expressing neurons controls energy balance</dc:title>
<dc:creator>Rebecca L Leshan</dc:creator>
<dc:creator>Megan Greenwald-Yarnell</dc:creator>
<dc:creator>Christa M Patterson</dc:creator>
<dc:creator>Ian E Gonzalez</dc:creator>
<dc:creator>Martin G Myers</dc:creator>
<dc:identifier>doi:10.1038/nm.2724</dc:identifier>
<dc:source>Nature Medicine 18, 820 (2012)</dc:source>
<dc:date>2012-04-22</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-04-22</prism:publicationDate>
<prism:doi>10.1038/nm.2724</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2724</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Letter</prism:section>
<prism:startingPage>820</prism:startingPage>
<prism:endingPage>823</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2724</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2720">
                     <title>Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/v_DsCdZpL7w/nm.2720</link>
<description>Finding new methods to define the target antigens recognized by MHC class I–restricted T cells is an unmet need. Katherina Siewert and her colleagues have developed a sensitive technique based on recombinatorial plasmid screening of T cell receptors (TCRs) isolated from individual T cells that overcomes many of the current limitations and enables the characterization of T cell antigens from most T cells, including those isolated from frozen biopsy samples by laser microdissection. The approach was validated using a well-characterized influenza virus–specific TCR, MHC and peptide combination.</description>
<content:encoded><![CDATA[

<p>
<b>Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides</b>
</p>
<p>Nature Medicine 18, 824 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2720">doi:10.1038/nm.2720</a>
</p>
<p>Authors: Katherina Siewert, Joachim Malotka, Naoto Kawakami, Hartmut Wekerle, Reinhard Hohlfeld &amp; Klaus Dornmair</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/v_DsCdZpL7w" height="1" width="1"/>]]></content:encoded>
<dc:title>Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides</dc:title>
<dc:creator>Katherina Siewert</dc:creator>
<dc:creator>Joachim Malotka</dc:creator>
<dc:creator>Naoto Kawakami</dc:creator>
<dc:creator>Hartmut Wekerle</dc:creator>
<dc:creator>Reinhard Hohlfeld</dc:creator>
<dc:creator>Klaus Dornmair</dc:creator>
<dc:identifier>doi:10.1038/nm.2720</dc:identifier>
<dc:source>Nature Medicine 18, 824 (2012)</dc:source>
<dc:date>2012-04-08</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-04-08</prism:publicationDate>
<prism:doi>10.1038/nm.2720</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2720</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Technical Report</prism:section>
<prism:startingPage>824</prism:startingPage>
<prism:endingPage>828</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2720</feedburner:origLink></item>
<item rdf:about="http://dx.doi.org/10.1038/nm.2721">
                     <title>A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle</title>
<link>http://feeds.nature.com/~r/nm/rss/current/~3/J2SD7GKHSP0/nm.2721</link>
<description>The ability to effectively assess tumor margins for brain tumor resection is a crucial factor in determining outcome in patients with brain tumors. Moritz Kircher and colleagues have developed a gold-silica nanoparticle that provides a triple-mode imaging capability of magnetic resonance, photoacoustic and Raman imaging, capitalizing on the complementary strengths of each modality for noninvasively delineating brain tumor margins both preoperatively and intraoperatively. The approach was tested in several mouse models, including one that recapitulates the infiltrating growth pattern of human gliomas.</description>
<content:encoded><![CDATA[

<p>
<b>A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle</b>
</p>
<p>Nature Medicine 18, 829 (2012).  
            <a href="http://dx.doi.org/10.1038/nm.2721">doi:10.1038/nm.2721</a>
</p>
<p>Authors: Moritz F Kircher, Adam de la Zerda, Jesse V Jokerst, Cristina L Zavaleta, Paul J Kempen, Erik Mittra, Ken Pitter, Ruimin Huang, Carl Campos, Frezghi Habte, Robert Sinclair, Cameron W Brennan, Ingo K Mellinghoff, Eric C Holland &amp; Sanjiv S Gambhir</p>
<img src="http://feeds.feedburner.com/~r/nm/rss/current/~4/J2SD7GKHSP0" height="1" width="1"/>]]></content:encoded>
<dc:title>A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle</dc:title>
<dc:creator>Moritz F Kircher</dc:creator>
<dc:creator>Adam de la Zerda</dc:creator>
<dc:creator>Jesse V Jokerst</dc:creator>
<dc:creator>Cristina L Zavaleta</dc:creator>
<dc:creator>Paul J Kempen</dc:creator>
<dc:creator>Erik Mittra</dc:creator>
<dc:creator>Ken Pitter</dc:creator>
<dc:creator>Ruimin Huang</dc:creator>
<dc:creator>Carl Campos</dc:creator>
<dc:creator>Frezghi Habte</dc:creator>
<dc:creator>Robert Sinclair</dc:creator>
<dc:creator>Cameron W Brennan</dc:creator>
<dc:creator>Ingo K Mellinghoff</dc:creator>
<dc:creator>Eric C Holland</dc:creator>
<dc:creator>Sanjiv S Gambhir</dc:creator>
<dc:identifier>doi:10.1038/nm.2721</dc:identifier>
<dc:source>Nature Medicine 18, 829 (2012)</dc:source>
<dc:date>2012-04-15</dc:date>
<prism:publicationName>Nature Medicine</prism:publicationName>
<prism:publicationDate>2012-04-15</prism:publicationDate>
<prism:doi>10.1038/nm.2721</prism:doi>
<prism:url>http://dx.doi.org/10.1038/nm.2721</prism:url>
<prism:volume>18</prism:volume>
<prism:number>5</prism:number>
<prism:section>Technical Report</prism:section>
<prism:startingPage>829</prism:startingPage>
<prism:endingPage>834</prism:endingPage>
<feedburner:origLink>http://dx.doi.org/10.1038/nm.2721</feedburner:origLink></item>
</rdf:RDF>

